Moving to Commercial Readiness with a Dedicated Analytical Platform for T-cell Therapies
Summary: Dr. Jef Pinxteren, Director of Process and Analytical Development at Catalent Cell and Gene Therapy, discusses a breadth of analytical methodologies, fill & finish approaches and manufacturing designs to accelerate CAR-T therapies to commercial readiness phase in this on-demand webinar.